about
New insights in diagnosis and treatment for Retinopathy of Prematurity.Color fundus photography versus fluorescein angiography in identification of the macular center and zone in retinopathy of prematurity.Influence of Fluorescein Angiography on the Diagnosis and Management of Retinopathy of Prematurity.Expert Diagnosis of Plus Disease in Retinopathy of Prematurity From Computer-Based Image Analysis.The Economic Model of Retinopathy of Prematurity (EcROP) Screening and Treatment: Mexico and the United States.Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy.Assessment of a Tele-education System to Enhance Retinopathy of Prematurity Training by International Ophthalmologists-in-Training in Mexico.Fibrin glue evaluation like an adjuvant in vitreo-retinal surgery.Retinal vascular changes in preterm infants: heart and lung diseases and plus disease.Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up.Optic disc and macula detection in fundus images by means of template matching.Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)Our experience after 1765 intravitreal injections of bevacizumab: the importance of being part of a developing storyComparison of iridocorneal angle in infants with retinopathy of prematurity and healthy infants using spectral domain optical coherence tomographyA proposal of an algorithm for the diagnosis and treatment of recurrence or treatment failure of retinopathy of prematurity after anti-VEGF therapy based on a large case series
P50
Q35894378-A5C9F650-C3B7-4F49-B797-8FBFA0AAB969Q36608683-37DD5073-FFC9-4474-9E96-59A96BB19183Q36709266-B07D6005-985C-4078-8B2E-4B2521477D59Q37545932-37355037-ED65-417A-AE21-C7B021FF5186Q39808424-7C5E682F-C1DF-46B4-A804-02C131BB6FB9Q40182273-1AA21ED3-6137-41DD-ACDD-A5F8B6FDF05BQ40254405-BBBFAB61-394F-4925-8515-C2110165249BQ42975522-0B5DAFD8-38A1-4DCB-8963-4DFB61B8A1D5Q47619437-5C8B419C-57EF-4847-9F1E-03933FF86762Q50778541-97B2CEEA-E41A-4B52-AB00-8E82889FA8ECQ50983511-BB8D0CDF-33D3-41A2-B6CC-61D147962CBBQ60197408-A107A807-2BF9-4B1C-897D-805F2101E729Q80469550-41DA7D72-0078-4B70-A141-E1FA7407C72EQ85220352-5E491693-003F-4098-B6F0-392B2D5F7E43Q92741240-3FDD292B-4382-4FD4-B536-37F504794ED7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maria Ana Martinez-Castellanos
@ast
Maria Ana Martinez-Castellanos
@en
Maria Ana Martinez-Castellanos
@es
Maria Ana Martinez-Castellanos
@nl
type
label
Maria Ana Martinez-Castellanos
@ast
Maria Ana Martinez-Castellanos
@en
Maria Ana Martinez-Castellanos
@es
Maria Ana Martinez-Castellanos
@nl
prefLabel
Maria Ana Martinez-Castellanos
@ast
Maria Ana Martinez-Castellanos
@en
Maria Ana Martinez-Castellanos
@es
Maria Ana Martinez-Castellanos
@nl
P106
P21
P31
P496
0000-0002-1265-3725